XML 60 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue - Revenue by Sales Category (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Net Sales $ 40,109 $ 43,653 $ 43,075
Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 40,095 43,642 43,023
Corporate, Non-Segment      
Segment Reporting Information [Line Items]      
Net Sales 14 11 52
United States      
Segment Reporting Information [Line Items]      
Net Sales 15,452 18,142 16,642
United States | Corporate, Non-Segment      
Segment Reporting Information [Line Items]      
Net Sales 14 11 34
International      
Segment Reporting Information [Line Items]      
Net Sales 24,657 25,511 26,433
International | Corporate, Non-Segment      
Segment Reporting Information [Line Items]      
Net Sales 0 0 18
Established Pharmaceutical Products | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 5,066 4,912 4,718
Established Pharmaceutical Products | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 0 0 0
Established Pharmaceutical Products | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 5,066 4,912 4,718
Nutritionals | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 8,154 7,459 8,294
Nutritionals | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,413 2,919 3,556
Nutritionals | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 4,741 4,540 4,738
Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 9,988 16,469 15,526
Diagnostics | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 4,329 8,531 7,011
Diagnostics | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 5,659 7,938 8,515
Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 16,887 14,802 14,485
Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 7,696 6,681 6,041
Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 9,191 8,121 8,444
Key Emerging Markets | Established Pharmaceutical Products | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,807 3,766 3,565
Key Emerging Markets | Established Pharmaceutical Products | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 0 0 0
Key Emerging Markets | Established Pharmaceutical Products | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,807 3,766 3,565
Other | Established Pharmaceutical Products | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,259 1,146 1,153
Other | Established Pharmaceutical Products | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 0 0 0
Other | Established Pharmaceutical Products | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,259 1,146 1,153
Pediatric Nutritionals | Nutritionals | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,934 3,481 4,298
Pediatric Nutritionals | Nutritionals | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,977 1,562 2,192
Pediatric Nutritionals | Nutritionals | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,957 1,919 2,106
Adult Nutritionals | Nutritionals | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 4,220 3,978 3,996
Adult Nutritionals | Nutritionals | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,436 1,357 1,364
Adult Nutritionals | Nutritionals | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,784 2,621 2,632
Core Laboratory | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 5,159 4,888 5,128
Core Laboratory | Diagnostics | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,243 1,137 1,145
Core Laboratory | Diagnostics | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,916 3,751 3,983
Molecular | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 574 995 1,427
Molecular | Diagnostics | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 172 370 566
Molecular | Diagnostics | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 402 625 861
Point of Care | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 565 525 536
Point of Care | Diagnostics | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 396 372 384
Point of Care | Diagnostics | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 169 153 152
Rapid Diagnostics | Diagnostics | Revision of Prior Period, Reclassification, Adjustment      
Segment Reporting Information [Line Items]      
Net Sales   (115) (118)
Rapid Diagnostics | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 3,690 10,061 8,435
Rapid Diagnostics | Diagnostics | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,518 6,652 4,916
Rapid Diagnostics | Diagnostics | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,172 3,409 3,519
Rhythm Management | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,255 2,119 2,198
Rhythm Management | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,085 1,029 1,018
Rhythm Management | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,170 1,090 1,180
Electrophysiology | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,195 1,927 1,907
Electrophysiology | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,008 909 778
Electrophysiology | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,187 1,018 1,129
Heart Failure | Medical Devices | Revision of Prior Period, Reclassification, Adjustment      
Segment Reporting Information [Line Items]      
Net Sales   115 118
Heart Failure | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,161 1,035 1,007
Heart Failure | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 888 809 772
Heart Failure | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 273 226 235
Vascular | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,681 2,483 2,654
Vascular | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 978 864 915
Vascular | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,703 1,619 1,739
Structural Heart | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,944 1,712 1,610
Structural Heart | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 883 818 730
Structural Heart | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 1,061 894 880
Neuromodulation | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 890 770 781
Neuromodulation | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 725 619 616
Neuromodulation | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 165 151 165
Diabetes Care | Medical Devices | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 5,761 4,756 4,328
Diabetes Care | Medical Devices | United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 2,129 1,633 1,212
Diabetes Care | Medical Devices | International | Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales $ 3,632 $ 3,123 $ 3,116